Successful creation of an anemia management algorithm for hemodialysis patients

References

• EschbachJWEgrieJCDowningMRBrowneJKAdamsonJWCorrection of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialN Engl J Med1987316273783537801
   PubMed Web of Science ®Google Scholar
• EschbachJWAbdulhadiMHBrowneJKRecombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trialAnn Intern Med19891111299210002688507
   PubMed Web of Science ®Google Scholar
• EschbachJWKellyMRHaleyNRAbelsRIAdamsonJWTreatment of the anemia of progressive renal failure with recombinant human erythropoietinN Engl J Med198932131581632747747
   PubMed Web of Science ®Google Scholar
• MaJZEbbenJXiaHCollinsAJHematocrit level and associated mortality in hemodialysis patientsJ Am Soc Nephrol199910361061910073612
   PubMed Web of Science ®Google Scholar
• LocatelliFPisoniRLCombeCAnaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)Nephrol Dial Transplant200419112113214671047
   PubMed Web of Science ®Google Scholar
• TsubakiharaYNishiSAkibaT2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney diseaseTher Apher Dial201014324027520609178
   PubMed Web of Science ®Google Scholar
• BesarabABoltonWKBrowneJKThe effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetinN Engl J Med199833995845909718377
   PubMed Web of Science ®Google Scholar
• CotterDJStefanikKZhangYThamerMImproved survival with higher hematocrits: where is the evidence?Semin Dial200417318118315144538
   PubMed Web of Science ®Google Scholar
• LocatelliFBárányPCovicAKidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statementNephrol Dial Transplant20132861346135923585588
   PubMed Web of Science ®Google Scholar
• USRDSorg [homepage on the Internet]Bethesda, MDNational Institutes of HealthNational Institute of Diabetes and Digestive and Kidney Diseases2014 Available from: http://www.usrds.org/adr.aspxAccessed March 29, 2015
   Google Scholar
• FDA.gov [homepage on the Internet]Rockville, MDThe US Food and Drug Administration2011 Available from: http://www.fda.gov/Drugs/DrugSafety/ucm259639.htmAccessed March 29, 2015
   Google Scholar
• PortolésJMde FranciscoALGórrizJLMaintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective studyKidney Int200874111S82S87
   Web of Science ®Google Scholar
• EbbenJPGilbertsonDTFoleyRNCollinsAJHemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizationsClin J Am Soc Nephrol2006161205121017699349
   PubMed Web of Science ®Google Scholar
• ThakuriaMOfsthunNJMullonCDiaz-BuxoJAAnemia management in patients receiving chronic hemodialysisSemin Dial201124559760221999745
   PubMed Web of Science ®Google Scholar
• BrierMEGawedaAEDaileyAAronoffGRJacobsAARandomized trial of model predictive control for improved anemia managementClin J Am Soc Nephrol20105581482020185598
   PubMed Web of Science ®Google Scholar
• GawedaAEAronoffGRJacobsAARaiSNBrierMEIndividualized anemia management reduces hemoglobin variability in hemodialysis patientsJ Am Soc Nephrol201425115916624029429
   PubMed Web of Science ®Google Scholar
• BrimbleKSRabbatCGMcKennaPLambertKCarlisleEJProtocolized anemia management with erythropoietin in hemodialysis patients: a randomized controlled trialJ Am Soc Nephrol200314102654266114514745
   PubMed Web of Science ®Google Scholar
• HoWRGermainMJGarbJUse of 12×/month haemoglobin monitoring with a computer algorithm reduces haemoglobin variabilityNephrol Dial Transplant20102582710271420176613
   PubMed Web of Science ®Google Scholar
• MurakamiKSuzukiTUchinoJThe influence that renal anemia management in the low ferritin (<60 ng/mL) gives to an anemia-related various factorsKidney and Dialysis2013743463467 [in Japanese]
   Google Scholar
• PattersonPAllonMProspective evaluation of an anemia treatment algorithm in hemodialysis patientsAm J Kidney Dis19983246356419774126
   PubMed Web of Science ®Google Scholar
• LinesSWLindleyEJTattersallJEWrightMJA predictive algorithm for the management of anaemia in haemodialysis patients based on ESA pharmacodynamics: better results for less workNephrol Dial Transplant20122762425242922207330
   PubMed Web of Science ®Google Scholar
• MiskulinDCWeinerDETighiouartHComputerized decision support for EPO dosing in hemodialysis patientsAm J Kidney Dis20095461081108819781831
   PubMed Web of Science ®Google Scholar
• KalickiRMUehlingerDERed cell survival in relation to changes in the hematocrit: more important than you thinkBlood Purif200826435536018493121
   PubMed Web of Science ®Google Scholar
• KanjiGKTest 17 F-Test for Two Population Variances (with Correlated Observations), in 100 Statistical Tests3rdLondon, UKSage20064647
   Google Scholar
• PisoniRLBragg-GreshamJLFullerDSFacility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): associations with mortality, patient characteristics, and facility practicesAm J Kidney Dis201157226627521251541
   PubMed Web of Science ®Google Scholar
• YangWIsraniRKBrunelliSMJoffeMMFishbaneSFeldmanHIHemoglobin variability and mortality in ESRDJ Am Soc Nephrol200718123164317018003781
   PubMed Web of Science ®Google Scholar
• KuoKLHungSCLinYPIntravenous ferric chloride hexahy-drate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patientsPLoS ONE2012712e5029510.1371/journal.pone.0050295 Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0050295Accessed March 29, 201523227165
   PubMed Web of Science ®Google Scholar
• HasuikeYNonoguchiHTokuyamaMSerum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya studyClin Exp Nephrol201014434935520467772
   PubMed Web of Science ®Google Scholar
• VosFESchollumJBCoulterCVDoyleTCDuffullSBWalkerRJRed blood cell survival in long-term dialysis patientsAm J Kidney Dis201158459159821715072
   PubMed Web of Science ®Google Scholar
• SatoYMizuguchiTShigenagaSShortened red blood cell lifespan is related to the dose of erythropoiesis-stimulating agents requirement in patients on hemodialysisTher Apher Dial201216652252823190511
   PubMed Web of Science ®Google Scholar
• MizuguchiTDosing regimens of erythropoiesis-stimulating agents in hemodialysis patients in terms of bone marrow hematopoiesisKidney and Dialysis2013751125132 [in Japanese]
   Google Scholar
• CoyneDWKapoianTSukiWFerric gluconate is highly effi-cacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients’ Response to IV Iron with Elevated Ferritin (DRIVE) StudyJ Am Soc Nephrol200718397598417267740
   PubMed Web of Science ®Google Scholar
• ChungMChanJAMoorthyD [Investigators]Biomarkers for assessing and managing iron deficiency anemia in late-stage chronic kidney disease: future research needs: identification of future research needs from comparative effectiveness review no 83Future Research Needs PapersRockville, the United StatesAgency for Healthcare Research and Quality20131Report No: 13-EHC038-EF Available from: http://www.ncbi.nlm.nih.gov/books/NBK143610/Accessed March 29, 2015
   Google Scholar
• NakanishiTHasuikeYNagasawaYKuraganoTHow much intravenous iron is utilized for erythropoiesis?Am J Med201312611e2710.1016/j.amjmed.2013.05.028 Available from: http://www.amjmed.com/article/S0002-9343%2813%2900733-X/fulltextAccessed March 29, 201524157298
   PubMed Web of Science ®Google Scholar